Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_assertion description "[Small-molecule inhibitors of MEK1/MEK2 are therefore viewed as attractive drug candidates for the targeted therapy of this malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_assertion evidence source_evidence_literature NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_assertion SIO_000772 19014680 NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_assertion wasDerivedFrom befree-20150227 NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_assertion wasGeneratedBy ECO_0000203 NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP646002.RAeO8R7vO4m-7T3qdP1hDTrvCoQV4-GsXnsOu3osmVSxc130_provenance.